FdaApplication
NDA 020241
Identifiers
- fda_app_no: NDA020241
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE LLC |
| application_type | NDA |
| approval_date | 1994-12-27 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMICTAL | LAMOTRIGINE | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| LAMICTAL | LAMOTRIGINE | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| LAMICTAL | LAMOTRIGINE | 200MG | TABLET;ORAL |
| LAMICTAL | LAMOTRIGINE | 25MG | TABLET;ORAL |
| LAMICTAL | LAMOTRIGINE | 150MG | TABLET;ORAL |
| LAMICTAL | LAMOTRIGINE | 100MG | TABLET;ORAL |
6 products